Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

All-case post-marketing surveillance of delamanid for treating multidrug-resistant pulmonary tuberculosis in Japan.

Respiratory investigation·2026
Same author

Combining tuberculin skin test with follow-on interferon gamma release assay markedly improves screening of household contacts.

Thorax·2025
Same author

Ambient PM<sub>2.5</sub> exposure and tuberculosis reactivation: a cross-sectional study in an intermediate burden city.

Epidemiology and infection·2025
Same author

No increased risk of tuberculosis-related immune reconstitution inflammatory syndrome with integrase inhibitor-based antiretroviral therapy in people with HIV with profound immunosuppression.

HIV medicine·2024
Same author

Association of smoking cessation with airflow obstruction in workers with silicosis: A cohort study.

PloS one·2024
Same author

Use of spirometry to detect airflow obstruction.

Respirology (Carlton, Vic.)·2024
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis in the global aging population.

Toru Mori1, Chi Chiu Leung

  • 1Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo 204-8533, Japan. tmori-rit@jata.or.jp

Infectious Disease Clinics of North America
|August 3, 2010
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) continues to be a significant health issue for older adults, posing challenges in diagnosis and treatment. This review explores TB in the elderly, covering epidemiology, risks, prevention, and clinical aspects.

Related Experiment Videos

Last Updated: Jun 10, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis incidence is decreasing globally but remains a concern in elderly populations.
  • Diagnosing and treating latent and active tuberculosis in older adults is challenging due to limited tools.
  • The aging population presents unique epidemiological and clinical considerations for tuberculosis control.

Purpose of the Study:

  • To review the current and future status of tuberculosis in the elderly.
  • To examine the epidemiology and risk factors associated with TB in older adults.
  • To discuss preventive treatment strategies and clinical disease management for elderly TB patients.

Main Methods:

  • Literature review of current research on tuberculosis in the elderly.
  • Analysis of epidemiological data and risk factors.
  • Evaluation of diagnostic and treatment challenges and strategies.

Main Results:

  • Tuberculosis poses a significant burden on the elderly population, despite overall incidence declines.
  • Existing diagnostic and treatment tools are often inadequate for this demographic.
  • Preventive strategies and tailored clinical approaches are crucial for managing TB in the elderly.

Conclusions:

  • Effective tuberculosis control in the elderly requires addressing limitations in current diagnostic and therapeutic tools.
  • Further research and development of age-specific interventions are needed.
  • A comprehensive approach focusing on epidemiology, risk factors, prevention, and clinical management is essential for combating TB in older adults.